Barclays lowered its price target on Molina Healthcare stock following an analyst report.
1 report, 1 independent
Updated Sep 5
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Barclays lowered its price target on Molina Healthcare stock following an analyst report.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Barclays
British bank
-
Molina Healthcare
American managed care company
Related events
- Barclays influenced price targets for Nasdaq. Analyst ratings affect market perception of Nasdaq.
- ISI (Twist Bioscience) was listed on the Nasdaq stock exchange, and Barclays raised its price target on the company on July 9, 2026.
- Multiple major banks, including Citigroup, UBS, Bank of America, and Barclays, have issued updated price targets and ratings.
Coverage
Newest first; wire copies grouped- StockStoryWhy Molina Healthcare (MOH) Stock Is Falling Today Shares of healthcare insurance company Molina Healthcare (NYSE:MOH) fell 4.8% in the morning session after Barclays lowered its price target on the